- Reported transaction lines
- 2
- Buy lines
- 0
- Sell lines
- 0
Filing activity by month
Original filing lines in up to 12 months with activity.
- 2026-112
Frequently disclosed stocks
Disclosure history
| Reporting investor | Security | Activity | Transaction / period | Filed | Reported amount | Source |
|---|---|---|---|---|---|---|
| Bruehlman Ronald E Director · GoodRx Holdings, Inc. | GDRX GoodRx Holdings, Inc. | Exercise or conversionFiling detailsSEC transaction code M Deferred Stock Unit · Derivative security · Direct ownership · Reported balance after transaction: 21692 · Each restricted stock unit represents a contingent right to receive one share of Class A common stock. · The deferred stock unit award vested as to one-third of the shares underlying the award on November 8, 2026. The deferred stock units will settle on the earliest to occur of the following events (i) December 31, 2029; (ii) Separation from Service; (iii) a Change in Control; (iv) death; or (v) Disability (each, as defined under the GoodRx Holdings, Inc. Deferred Compensation Plan for Directors). | 2026-11-08 | 2026-11-09 | 21,692 shares/units | SEC 4 |
| Bruehlman Ronald E Director · GoodRx Holdings, Inc. | GDRX GoodRx Holdings, Inc. | Exercise or conversionFiling detailsSEC transaction code M Class A Common Stock · Direct ownership · Reported balance after transaction: 229044 · The deferred stock unit award vested as to one-third of the shares underlying the award on November 8, 2026. The deferred stock units will settle on the earliest to occur of the following events (i) December 31, 2029; (ii) Separation from Service; (iii) a Change in Control; (iv) death; or (v) Disability (each, as defined under the GoodRx Holdings, Inc. Deferred Compensation Plan for Directors). | 2026-11-08 | 2026-11-09 | 21,692 shares/units | SEC 4 |
Counts describe original filing lines in BriefStock’s coverage. Later amendments can correct or supplement them. Check the original filing for ownership and transaction details.